Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003864:Depression, Chemical; D004106:Dilatation; D004305:Dose-Response Relationship, Drug; D004987:Ethers / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D006973:Hypertension / Q000188:drug therapy / Q000517:prevention & control; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D004987:Ethers; D011412:Propanolamines; D011437:Propylamines; D011433:Propranolol; D007545:Isoproterenol